febuxostat has been researched along with acacetin in 1 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (acacetin) | Trials (acacetin) | Recent Studies (post-2010) (acacetin) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 231 | 1 | 159 |
| Protein | Taxonomy | febuxostat (IC50) | acacetin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.083 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.1655 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.167 | |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | 3.3 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.049 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.6967 | |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | 5.78 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 5.78 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.011 | |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 5.7 | |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | 9.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderluh, M; Jakopin, Ž; Kocić, G; Petronijević, Ž; Šmelcerović, A; Šmelcerović, Ž; Tomašič, T; Tomović, K | 1 |
1 review(s) available for febuxostat and acacetin
| Article | Year |
|---|---|
Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
Topics: Allopurinol; Computer Simulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Humans; Molecular Structure; Structure-Activity Relationship; Xanthine Oxidase | 2017 |